Navigation Links
Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
Date:7/16/2008

Raptor to Support Phase 2a Clinical Trial at UCSD

NOVATO, Calif., July 16 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreement (the "Agreement") with the University of California, San Diego ("UCSD") to include a Phase 2a clinical trial to evaluate a delayed-release preparation of cysteamine bitartrate ("Cysteamine") in adolescents diagnosed with Non-Alcoholic Steatohepatitis ("NASH"). NASH is a progressive form of liver disease that accounts for approximately 10% of newly diagnosed cases of chronic liver disease, and ranks as one of the leading causes of cirrhosis of the liver in the U.S.

Under the terms of the Agreement, clinical researchers from UCSD will perform the Phase 2a study at the University's General Clinical Research Center, and Raptor will provide funding and clinical supply of Cysteamine. In March 2008, Raptor acquired an exclusive, worldwide license to certain intellectual property and development rights from UCSD surrounding the use of Cysteamine as a potential treatment for NASH.

A rapid-release form of Cysteamine is currently approved for sale by the U.S. Food and Drug Administration ("FDA") for the treatment of nephropathic cystinosis, a rare, genetic lysosomal storage disease. Raptor is currently developing DR Cysteamine, a proprietary, delayed-release formulation of Cysteamine, designed to improve bioavailability and potentially reduce side effects associated with the presently marketed form.

Ted Daley, President of Raptor's clinical division stated, "We look forward to working with UCSD, one of the leading research universities in the nation, under this collaboration agreement. The University's clinical researchers have specific expertise in treating NASH patients, and have also worked extensively with Cysteamine. We are fortunate to work with this team to investigate our drug candidate
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
2. Raptor Pharmaceuticals Provides Update of Product Programs
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
5. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
6. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
7. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
10. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Biotel Inc. (OTC Bullet...arter ended September 30, 2009 with net earnings o...s of $3,263,000. This compares to net earnings of... of $3,168,000 for the first quarter of last year....otel President and CEO Steve Springrose said: "Bio...
(Date:11/20/2009)..., Pa., Nov. 20 In respo...tions why currently available medications designed...ed, ECRI Institute, an independent nonprofit organ... Finasteride for Prevention of Prostate Cancer fo...ew York Times article, " Drugs to Deter Some Canc...
(Date:11/20/2009)...v. 20 Smith & Nephew...to announce the signing of a technology developmen...fense that may lead to the creation of a fracture ...tment of the limbs of soldiers who sustain battlef...ed Research Projects Agency (DARPA), the central r...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Study supports validity of test that indicates widespread unconscious bias 49273 1Study supports validity of test that indicates widespread unconscious bias 49273 2Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 1Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 2Critical Information Network 28CiNet 28TM 29 29 Launches to Provide eLearning Solutions to Public Safety Healthcare and Industrial Operations Profes 49270 3Taking Aim at Relapse of Leukemia in Kids 49267 1Taking Aim at Relapse of Leukemia in Kids 49267 2
...April 23, 2007 /PRNewswire-FirstCall/,Micromet, In...in,its research collaboration with MedImmune, Inc....eting carcinoembryonal antigen (CEA),a validated ...various human carcinomas. Preclinical data recentl...ican Association for Cancer,Research (AACR) showed...
...f.--(BUSINESS WIRE)--Apr 23, 2007 - Aeolus,Pharmac...tion of,data by researchers at Loma Linda Universi...s metalloporphyrin antioxidants, AEOL,10113, may p...age,induced by ionizing radiation., Radiation ther...nd chemotherapy in the care and management of near...
Other Medicine Technology:Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune 2Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune 3Micromet Achieves Milestone in BiTE Research Collaboration with,MedImmune 4Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 2Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 3
(Date:11/22/2009)...he holiday season is filled with get-togethers wit...s. It can also be stressful and tiring at times. E...gue, and high fat foods -- factors that can, over ... National Foundation for Cancer Research has devel...re a happier, more healthful holiday season, and c...
(Date:11/21/2009).... 21 DNC Chairman Tim K...te voted to begin full debate of health insurance ...com.com/cgi-bin/prnh/20080519/DNCLOGO ) ,, "T... road to enacting health insurance reform. By clea...ow have an opportunity to debate the health reform...
(Date:11/21/2009)...scusses Key Provisions of Legislation, Continues P...CHARLES, Ill., Nov. 21 ...he landmark Affordable Health Care for America Act...orm legislation forward, Congress has taken decisi...stem. Today, AARP hosted an educational forum to ...
(Date:11/21/2009)...APPYneuron,s most popular and addictive game, Spli...uch. , Mountain View, CA ...pular and addictive game, SplitWords, is now avail...designed to help banish that ,tip of the tongue, s... game challenges the brain by encouraging users t...
(Date:11/20/2009)...logist Closer to Understanding Brain Wiring and Di...swire/ -- Dr. Jeremy Schmahmann, Professor of Neur... the Massachusetts General Hospital in Boston, on ...research on the new field of study called "Connect..., Dr. Schmahmann is an award-winning leader in ...
Breaking Medicine News(10 mins):Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
... of Circulation: Journal of the America Heart Asso...out heart healthy eating habits, it can strongly i... , Results from the Turku Coronary Risk Factor In...ake of saturated fat, was found to be one of the g...
...ustry is riding the green wave back into public fa...ur growing energy needs. But even as the industry ...ically play, it is bound by a global energy landsc...kes a pragmatic look at the trade-offs associated ...
...ilol , , TUESDAY, Sept. 11 (HealthDay News...r drug family that has been effective for adults w...condition, a new study found. , The rate of improv...lacebo. , "Heart failure in children is both not c...
... resulted in a cancer diagnosis among a population...did not find cancer often had multiple biopsies in...r diagnosis. , While PSA (prostate-specific anti... remains unclear whether or not PSA screening actu...
... finds having at least some education beyond high ...er death. The study finds higher education levels ...tality among black men, white men, and white women...ious studies have found that death rates are highe...
... the University of Oregon and requiring no more th...doctors appointment is credited with a 224-percent...children with mild developmental delays in a yearl...n made without the Ages & Stages Questionnaires (A...
Other Medicine News:Health News:Children who learn heart healthy eating habits lower heart disease risk 2Health News:Children who learn heart healthy eating habits lower heart disease risk 3Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Beta Blocker Doesn't Help Children With Heart Failure 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3Health News:Study links education to risk of cancer death 2Health News:Study links education to risk of cancer death 3Health News:Parental surveys boost diagnosis abilities of pediatricians 2Health News:Parental surveys boost diagnosis abilities of pediatricians 3
C-Reactive Protein - Rapid Test
...graphic in vitro assay for detection of elevated l.... Elevated concentration of IgE is commonly associ...sed by autoimmune diseases and some infections. Ra...will help in diagnosis and monitoring of IgE-media...
...ly therapy solution open to them is to be given a ...ways readily available. For this reason, too many ...a donor organ. , ,This is where ventricular as... On the one hand, these systems can bridge the wai...
...tease that is found only in the prostate within th...PSA concentration in whole blood or serum is 0.1-2...el of whole blood or serum PSA is the must useful ...staTest PSA is designed to detect PSA concentratio...
Medicine Products: